Saint Genis Laval, France

Elodie Mandon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elodie Mandon: Innovator in Immunoprotective Proteins

Introduction

Elodie Mandon is a notable inventor based in Saint Genis Laval, France. She has made significant contributions to the field of immunology, particularly through her innovative work on immunoprotective proteins. Her research focuses on eliciting protective immunity in animals against various pathogens.

Latest Patents

Elodie Mandon holds 1 patent for her invention related to immunoprotective proteins and methods of identification and use thereof. The present invention provides compositions and methods for eliciting heterologous protective immunity in animals against specific pathogens. The immunoprotective peptides disclosed in her patent elicit protective immunity against subsequent challenges or exposures to at least two serovars.

Career Highlights

Throughout her career, Elodie has worked with prominent organizations, including Boehringer Ingelheim Animal Health USA Inc. Her work has contributed to advancements in animal health and immunology, showcasing her dedication to improving protective measures against diseases.

Collaborations

Elodie has collaborated with notable professionals in her field, including Natalia Ines Bomchil and Jean-Baptiste Claude. These collaborations have further enriched her research and development efforts.

Conclusion

Elodie Mandon's innovative work in immunoprotective proteins highlights her commitment to advancing animal health through scientific research. Her contributions are paving the way for new methods of disease prevention in veterinary medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…